Sekunjalo, U.S. Co. Partner on Cancer Vaccines: Business Report
This article is for subscribers only.
Sekunjalo Investment Holdings, Genius Biotherapeutics, to develop therapeutic vaccines for cancer in South Africa, Johannesburg-based newspaper says, citing U.S.-based co. * Research project being tested and developed in collaboration with University of Cape Town * NOTE: Genius in strategic alliance with Hemisperhx Biopharma of U.S. for manufacture, development of new drugs for treatment of viral, immune disorders